CDKN2A and colorectal carcinoma: The present study raised the possibility that CDKN2A inactivation could be an early event in inflammation-associated CRC, which is consistent with previous studies showing that the methylation of p14 and p16 is a relatively common early event in UC-associated carcinogenesis35,36.